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Abstract
BACKGROUND—Although the incidence of gastroschisis is increasing, risk factors are not 
clearly identified.
METHODS—Using the Linked Birth Database from the California Office of Statewide Health 
Planning and Development from 1995–2012, patients with gastroschisis were identified by ICD-9 
diagnosis/procedure code or birth certificate designation. Logistic regressions examined 
demographics, birth factors, and maternal exposures on risk of gastroschisis.
RESULTS—The prevalence of gastroschisis was 2.7 cases per 10,000 live births. Patients with 
gastroschisis had no difference in fetal exposure to alcohol (p=0.609), narcotics (p=0.072), 
hallucinogenics (p=0.239), or cocaine (p=0.777), but had higher exposure to unspecified/other 
noxious substances (OR 3.27, p=0.040; OR 2.02, p=0.002). Gastroschisis was associated with low/
very low birthweight (OR 5.08–16.21, p<0.001) and pre-term birth (OR 3.26–10.0, p<0.001). 
Multivariable analysis showed lower risk in black (OR 0.44, p<0.001), Asian/Pacific Islander (OR 
0.76, p=0.003), and Hispanic patients (OR 0.72, p<0.001) compared to white patients. Risk was 
higher in rural areas (OR 1.24–1.76, p=0.001). Compared to women age<20, risk decreased with 
advancing maternal age (OR 0.49-OR 0.03, p<0.001). Patients with gastroschisis had increased 
total charges ($336,270 vs. $9,012, p<0.001) and length of stay (38.1 vs. 2.9 days, p<0.001). 
Mortality was 4.6%.
CONCLUSIONS—This is the largest population-based study summarizing current epidemiology 
of gastroschisis in California.
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INTRODUCTION
There is evidence the prevalence of gastroschisis is increasing worldwide, [1–7] but the 
etiology of gastroschisis is not well understood. Young maternal age is the most commonly 
cited risk factor,[1,5, 8] but it is unclear whether the risk is inherent in young women or is 
simply a confounder for another exposure that is more common in younger women. 
Interestingly, the incidence of gastroschisis is increasing for women of all ages, not solely in 
younger women.[1] Other cited risk factors include white race,[9] nulliparity,[10] tobacco 
use,[10] sexually transmitted diseases,[11] exposure to non-steroidal anti-inflammatory 
drugs,[12] exposure to vasoconstrictors,[13] and exposure to herbicides (atrazine),[10, 14] 
among others.
The aim of this study is to identify trends in epidemiology, risk factors, and outcomes of 
gastroschisis using a population database in California, one of the most populous and diverse 
states in the U.S.
1. MATERIALS AND METHODS
This is a retrospective, observational population analysis using data from the Linked Birth 
Database from the California Office of Statewide Health Planning and Development from 
1995–2012. This database includes information on all births in California, including infant 
birth records and readmissions within one year as well as maternal antepartum and 
postpartum hospital records. It links information from the following datasets: California 
Patient Discharge Data, Vital Statistics Birth/Death Certificate Data, Vital Statistics Fetal 
Death Data, and Vital Statistics Birth Cohort File.
Patients with gastroschisis were identified by an ICD-9 procedure code for gastroschisis 
repair (54.71); ICD-9 diagnosis code for gastroschisis (756.73, available since 2009); or 
birth certificate designation for gastroschisis (available since 2006).
Maternal factors included race, ethnicity, age, highest educational level achieved, county of 
residence, and birth history. Counties were identified as rural, partially rural (metropolitan 
counties with some rural census tracks), and metropolitan, according to 2010 census data.
[15]
Birth data included method of delivery, whether or not the patient labored (regardless of 
whether Caesarean section was ultimately performed), and time of day of delivery. Season of 
conception and birth were also identified.
Fetal exposure to certain substances were identified by ICD-9 diagnosis codes. Drug 
exposures included: alcohol (760.71), narcotics (760.72), hallucinogenics (760.73), cocaine 
(760.75), unspecified noxious substances (760.70), and other noxious substances (760.79).
Length of stay, total charges during birth hospitalization, and mortality were compared 
between patients with and without gastroschisis using Student’s t-test, non-parametric 
equality of medians test, and Chi-squared analyses. Univariate and multivariable logistic 
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regressions examined demographics, birth factors, and maternal exposures on the risk of 
gastroschisis.
Statistical analysis was performed using Stata/SE version 14.2. This study was approved by 
the UC Davis Institutional Review Board and the California Committee for the Protection of 
Human Subjects.
2. RESULTS
From 1995–2012, 2,527 infants with gastroschisis were born in California, resulting in a 
population prevalence of 2.7 cases per 10,000 live births during the study timeframe (Table 
1). The prevalence increased during this time period from 1.5 to 5.3 cases per 10,000 live 
births.
2.1 Demographics
On unadjusted analysis of race, the prevalence was highest in the white population (2.81 
cases per 10,000 live births) and other racial groups (3.31 cases per 10,000 live births), and 
lowest in the Asian/Pacific Islander population (1.46 cases per 10,000 live births; Table 1). 
Patients of Hispanic ethnicity also had higher than overall prevalence rates at 3.03 cases per 
10,000 live births.
Prevalence differences by race were consistent on univariate logistic regression (Table 2). 
Compared to white non-Hispanic patients, black/African American or Asian/Pacific Islander 
patients had decreased odds of gastroschisis (OR 0.69, p<0.001; OR 0.52, p<0.001), 
whereas Native American/Eskimo and other racial groups had higher odds (OR 1.61, 
p=0.040; OR 1.17, p=0.002). On univariate analysis, odds ratios were also increased among 
Hispanic ethnicity (OR 1.25, p<0.001).
Compared to patients with government insurance for prenatal care, patients with private 
insurance or self-pay had decreased odds ratios of gastroschisis (OR 0.51, p<0.001; OR 
0.43, p<0.001, respectively).
Compared to women age<20, odds of gastroschisis decreased with advancing maternal age 
(age 20–24: OR 0.52, p<0.001; age 25–29: OR 0.18, p<0.001; age 30–34: OR 0.08, 
p<0.001; age 35+: OR 0.03, p<0.001).
2.2 Prenatal and Birth Characteristics
There was no difference in length of time of prenatal care between patients with and without 
gastroschisis (Table 3). While there was no difference in season of conception, patients with 
gastroschisis were more likely to be born in the fall compared to the spring (OR 1.13, 
p=0.030). Patients with gastroschisis were not more likely to be born at night (between 5:00 
PM and 7:00 AM), and were less likely to be born on the weekend (OR 0.84, p=0.001).
Mothers of patients with gastroschisis were less likely to be allowed to labor (OR 0.32, 
p<0.001) and much more likely to give birth via Caesarean section (OR 3.29, p<0.001). The 
proportion of patients with gastroschisis undergoing Caesarean section has not changed over 
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time (p=0.079, data not shown). Patients with gastroschisis were more likely to be born pre-
term and with low birth weight (<2.5 kg). Multiple births were less likely with gastroschisis 
(OR 0.58, p<0.001).
2.3 Fetal exposures
Patients with gastroschisis had increased odds of exposure to unknown drugs or other 
noxious substances, but not specifically to alcohol, cocaine, narcotics, or hallucinogenics 
(Table 4).
2.4 Multivariable logistic regression
In a model including the most significant risk factors for gastroschisis, multivariable logistic 
regression showed lower odds of gastroschisis among black (OR 0.44, p<0.001), Asian/
Pacific Islander (OR 0.76, p=0.003), and Hispanic patients (OR 0.72, p<0.001) compared to 
white, non-Hispanic patients (Table 5). Importantly, the increase in odds of gastroschisis 
with Hispanic ethnicity seen on univariate analysis is decreased when including these 
additional variables. Consistent with the univariate analyses, the multivariable regression 
demonstrated a decrease in risk with an increase in maternal age (compared to women <20, 
OR 0.49–0.03, p<0.001); and an increase in risk in partially rural (OR 1.24, p=0.001) and 
rural counties (OR 1.76, p<0.001) compared to urban counties. Multivariable regression 
confirmed an increase in risk over time and an increased risk with unknown or other noxious 
drug exposures (OR 1.58, p=0.005).
2.5 Outcomes
Overall, 104 patients with gastroschisis (4.6%) died (Table 6). Median age of death was 26.5 
days (IQR 4.5–83 days). There was no difference in the mortality rate among patients with 
gastroschisis over time (p=0.060). The mortality rate among patients with gastroschisis was 
higher in patients who were born pre-term (<37 weeks) versus term (5.6% vs. 3.6%, 
p=0.027), but there was no difference comparing low-birth weight (<2.5 kg) to normal birth 
weight (p=0.225). Mean length of stay among patients with gastroschisis was significantly 
higher than patients without gastroschisis (38.1 days vs. 2.9 days, p<0.001). Total charges 
averaged over $336,000 for patients with gastroschisis, which was significantly higher than 
the $9,102 in patients without gastroschisis (p<0.001).
3. DISCUSSION
The prevalence of gastroschisis in California from 1995–2012 was 2.7 cases per 10,000 live 
births, but has increased during this time period from 1.5 to 5.3 cases per 10,000 live births. 
The increasing prevalence in California is concordant with ongoing concerns of a worldwide 
increase in the prevalence of gastroschisis.[1–7]
The highest risk in California continues to be among mothers who are white, young, and live 
in rural areas. Although mothers of Hispanic ethnicity had higher unadjusted prevalence 
rates of gastroschisis, risk of gastroschisis in mothers of Hispanic ethnicity was actually 
lower than non-Hispanic mothers in a multivariable analysis adjusting for other factors. 
These findings are similar to other states; in a study of 14 states in the U.S. (including 
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California), unadjusted prevalence was highest among non-Hispanic white mothers, 
followed by Hispanic mothers, then non-Hispanic black mothers in women less than age 25.
[3]
Several other studies have found that the risk of gastroschisis is higher in rural areas,[8] but 
this has not been extensively studied in California. The higher risk in rural areas has 
previously been attributed to agricultural exposures, such as atrazine.[10,14] Although we 
were unable to analyze environmental or agricultural exposures in detail in this study, the 
risk of gastroschisis did not vary by season of conception, decreasing the likelihood that this 
geographic difference is due to agricultural exposures that are typically seasonal.
Among fetal drug exposures, risk is only highest among unknown or other drugs or noxious 
substances, not alcohol, cocaine, narcotics, or hallucinogenics. It is impossible to determine 
what these other drugs or noxious substances may be, but marijuana and methamphetamine 
would likely be included in these categories. Given the association of gastroschisis with 
vasoconstricting medications,[13] maternal exposure to methamphetamines may be a risk 
factor for gastroschisis. Future studies are certainly needed to determine the relationship of 
marijuana and methamphetamines to gastroschisis.
Given these findings, younger, white mothers in rural areas of California may have other 
exposures beyond agricultural contaminants that increase risk of gastroschisis in this 
population. These young mothers remain vulnerable and efforts should continue to seek to 
identify risk factors and monitor further increases in prevalence of gastroschisis in this 
population.
Consistent with the literature, patients with gastroschisis are still more likely to be born pre-
term and with low birth weight. Mothers are also still less likely to be allowed to labor and 
more likely to give birth via Caesarean section. We also found that Caesarean section rates in 
gastroschisis have not changed over time in California. Other studies suggest that mode of 
delivery is not associated with survival of infants with gastroschisis;[16] we thus would 
expect to see these practices change to increase rates of spontaneous labor and decrease rates 
of Caesarean section.
We calculated a one-year mortality rate of 4.6%, which is higher than in other studies. In a 
cohort of 393 patients with gastroschisis in the U.K. and Ireland from 2006–2008, the 
mortality rate was 1.5%, [17] and in a cohort of 409 patients with gastroschisis in Canada 
from 2005–2010, the mortality rate was 3.2%.[18] Although these studies are not exactly 
analogous as their follow-up period was limited to the birth admission, the higher mortality 
rate and the lack of improvement over time in this study are concerning. Since neonates with 
gastroschisis who were born pre-term had higher mortality rates than those born at term, 
interventions to prolong pregnancy until term is one potential solution in this population.
We also identified a mean length of stay of 38.1 days and total charges averaging over 
$336,000. Although patients with gastroschisis typically have relatively good long-term 
outcomes, especially compared to other congenital anomalies or pediatric surgical 
emergencies, it is important to remember that even in California, this congenital anomaly 
does have significant mortality, morbidity, and cost. Being cognizant of this mortality rate 
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and other outcomes is useful for counseling and preparing parents of patient with 
gastroschisis.
3.1 Limitations
The primary limitation is that this study uses hospital discharge data and thus relies accurate 
physician chart documentation and accurate coding to correctly identify cases of 
gastroschisis. Birth certificate designations for congenital anomalies (including gastroschisis 
and omphalocele, separately) were created in 2006. Thus, the accuracy in identifying cases 
of gastroschisis has increased since 2006. Prior to 2009, the ICD-9 diagnosis code for 
gastroschisis also included omphalocele, so was not used in this analysis. It is thus possible 
we missed some cases of gastroschisis prior to 2006 since we were unable to distinguish 
these cases from omphalocele.
We are also unable to distinguish between the severity/type of gastroschisis (i.e. simple 
versus complex) or clarify type of closure performed. Epidemiology and outcomes may vary 
by these groups.
Identifying accurate fetal drug exposures is somewhat limited using ICD-9 diagnosis coding. 
For example, the drugs or substances included with unknown or other noxious substances 
are unclear (ICD-9 diagnosis codes 760.70, 760.79). Many of these challenges are improved 
with ICD-10 coding, but we are unable to tease out specific exposures with the current data.
There may also be a Hawthorne effect related to fetal exposures; mothers of patients with 
gastroschisis may be more heavily questioned on their drug use and other exposures. This 
may have artificially increased the risk of other or unspecified noxious or drug exposures.
3.2 Conclusion
The risk of gastroschisis continues to be highest in young, white mothers, and in rural 
counties. The prevalence is also increasing in California. Although the mortality is relatively 
low (4.7%), the prolonged hospitalization (>30 days) and high hospital charges (>$300,000) 
signify the ongoing high morbidity and cost of this congenital anomaly.
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Table 1.
Patient demographics and unadjusted prevalence by race
All patients
(n=9,306,007)
Gastroschisis
(n=2,527,
0.03%)
Without
Gastroschisis
(n=9,303,480,
99.97%)
P-Value
Cases per
10,000 live
births
Female sex – n (%) 4,543,692 (48.8) 1,213 (48.0) 4,542,479 (48.8) 0.701 2.67
Race – n (%) <0.001
 White 5,941,180 (64.9) 1,667 (67.3) 5,939,513 (64.9) 2.81
 Black 551,366 (6.0) 106 (4.2) 551,260 (6.0) 1.92
 Asian/Pacific Islander 947,926 (10.4) 138 (5.6) 947,788 (10.4) 1.46
 Other 1,710,065 (18.7) 566 (22.8) 1,709,499 (18.7) 3.31
Hispanic ethnicity – n (%) 4,221,896 (46.6) 1,282 (52.2) 4,220,614 (46.6) <0.001 3.03
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Table 2.
Univariate logistic regressions predicting gastroschisis: Demographics
Variable Odds Ratio (95% CI) P-Value
Patient demographics
Female sex 0.97 (0.89–1.05) 0.403
Race:
 White Ref
 Black 0.69 (0.56–0.83) <0.001
 Asian/Pacific Islander 0.52 (0.44–0.62_ <0.001
 Native American/Eskimo 1.61 (1.02–2.52) 0.040
 Other 1.17 (1.06–1.29) 0.002
Hispanic ethnicity 1.25 (1.16–1.35) <0.001
Insurance (Prenatal):
 Government (MediCare, MediCal, etc.) Ref
 Private 0.51 (0.47–0.56) <0.001
 Self-pay/no charge 0.43 (0.32–0.59) <0.001
Maternal demographics
Age <20 Ref
 20–24 0.52 (0.47–0.56) <0.001
 25–29 0.18 (0.16–0.20) <0.001
 30–34 0.08 (0.08–0.10) <0.001
 35+ 0.03 (0.02–0.04) <0.001
Urban vs. rural county
 Urban Ref
 Metropolitan counties with some rural census tracts 1.60 (1.42–1.81) <0.001
 Completely rural 3.04 (2.37–3.89) <0.001
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Table 3.
Univariate logistic regressions predicting gastroschisis: Prenatal and birth characteristics
Variable Odds Ratio (95%
CI)
P-Value
Months of prenatal care
 0 Ref
 1–3 1.15 (0.66–1.98) 0.624
 4–6 1.34 (0.77–2.32) 0.298
 7–9 1.07 (0.60–1.92) 0.810
Season of conception
 Spring Ref
 Summer 0.96 (0.85–1.07) 0.455
 Fall 1.10 (0.98–1.23) 0.106
 Winter 0.92 (0.83–1.03) 0.155
Season of birth
 Spring Ref
 Summer 1.05 (0.94–1.17) 0.440
 Fall 1.13 (1.01–1.27) 0.030
 Winter 0.94 (0.84–1.05) 0.279
Night birth (between 5 PM and 7 AM) 0.95 (0.88–1.03) 0.193
Weekend birth 0.84 (0.77–0.93) 0.001
Emergent (not scheduled) admission 1.14 (1.04–1.25) 0.003
Allowed to labor 0.32 (0.30–0.35) <0.001
Caesarean section 3.29 (3.05–3.56) <0.001
Gestational age at birth
 Term (37+ weeks) Ref
 Moderate/late pre–term (32–36.6 weeks) 10.0 (9.23–10.89) <0.001
 Very preterm (28–31.6 weeks) 4.98 (3.87–6.41) <0.001
 Extremely preterm (<28 weeks) 3.26 (2.24–4.75) <0.001
Birth weight
 >4.2 kg 0.16 (0.08–0.29) <0.001
 2.5–4.2 kg Ref
 1.5–2.49 kg 16.21 (14.97–17.55) <0.001
 <1.5 kg 5.08 (4.04–6.37) <0.001
Multiple births 0.58 (0.43–0.78) <0.001
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Table 4.
Univariate logistic regressions predicting gastroschisis: Fetal exposures
Variable Odds Ratio (95% CI) P-Value
Drug exposure (any of the following) 1.87 (1.34–2.61) <0.001
 Alcohol 1.67 (0.23–11.85) 0.609
 Cocaine 1.15 (0.43–3.07) 0.777
 Narcotics 1.82 (0.95–3.51) 0.072
 Hallucinogenic 2.30 (0.57–9.19) 0.239
 Noxious substance (other drugs) 3.27 (1.05–10.15) 0.040
 Other noxious substances 2.02 (1.29–3.18) 0.002
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Table 5.
Multivariable logistic regression predicting gastroschisis
Variable Odds Ratio (95% CI) P-Value
Race:
 White Ref
 Black 0.44 (0.36–0.55) <0.001
 Asian/Pacific Islander 0.76 (0.64–0.91) 0.003
 Native 1.19 (0.73–1.92) 0.482
 American/Eskimo 1.05 (0.94–1.16) 0.394
 Other
Hispanic 0.72 (0.65–0.78) <0.001
Maternal age (years):
 <20 Ref
 20–24 0.49 (0.44–0.53) <0.001
 25–29 0.16 (0.14–0.18) <0.001
 30–34 0.07 (0.06–0.09) <0.001
 35+ 0.03 (0.02–0.04) <0.001
Urban vs. rural county
 Urban Ref
 Metropolitan counties with some rural census tracts 1.24 (1.10–1.40) 0.001
 Completely rural 1.76 (1.36–2.28) <0.001
Year of birth
 1995 Ref
 1996 0.96 (0.71–1.30) 0.787
 1997 0.92 (0.68–1.25) 0.608
 1998 0.90 (0.66–1.23) 0.519
 1999 1.06 (0.79–1.43) 0.682
 2000 0.94 (0.69–1.28) 0.692
 2001 1.37 (1.03–1.81) 0.028
 2002 1.15 (0.86–1.54) 0.356
 2003 1.50 (1.13–1.97) 0.004
 2004 1.31 (0.99–1.75) 0.062
 2005 1.19 (0.89–1.59) 0.239
 2006 2.18 (1.69–2.82) <0.001
 2007 2.33 (1.81–3.00) <0.001
 2008 2.26 (1.75–2.92) <0.001
 2009 2.63 (2.04–3.38) <0.001
 2010 2.93 (2.28–3.76) <0.001
 2011 3.40 (2.66–4.35) <0.001
 2012 3.79 (2.97–4.84) <0.001
Drug exposure* 1.58 (1.01–2.49) 0.005
*
Includes other and unknown noxious substances.
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Table 6.
Outcomes during birth hospitalization
All patients
(n=9,306,007)
Gastroschisis
(n=2,527, 0.03%)
Without
Gastroschisis
(n=9,303,480,
99.97%)
P-Value
Died – n (%) 43,034 (0.5) 104 (4.6) 42,930 (0.5) <0.001
Length of stay – mean (days), 95% CI 2.8 (2.9–2.9) 38.1 (36.5–39.6) 2.9 (2.9–2.9) <0.001
Total charges – mean ($), 95% CI 9,101 (9,060–9,142) 336,270 (317,703–354,837) 9,012 (8,971–9,053) <0.001
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